← Latest Filings
C

Casdin Eli

Open-market buys
20
$47.0M total
Open-market sells
4
$49.5M total
Tracking since
Oct 2025
Open-market buy — $2.6M
GeneDx Holdings Corp. · Jun 5, 2026
Open-market buy — $8.5M
GeneDx Holdings Corp. · Jun 4, 2026
Open-market trades from the last two years.
72,100,000 Common Stock in LAB
Held indirectly (Casdin Partners Master Fund, L.P.) · as of 2026-06-18
13,939,637 Common Stock in LAB
Held indirectly (Casdin Private Growth Equity Fund II, L.P.) · as of 2026-06-18
STANDARD BIOTOOLS INC.
CIK 0001162194
GeneDx Holdings Corp.
CIK 0001818331